L5: Introduction to Pharmacokinetics Flashcards

1
Q

What is a therapeutic window?

A

Range of concentration of a drug between maximum safe and minimum effective concentrations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the pillars of pharmacokinetics?

A
  • Absorption - transfer of drug to circulation (how quickly the drug is absorbed to the system)
  • Distribution - where drug reaches (how is it distributed)
  • Metabolism - (how drug is acted upon)
  • Elimination - removal of a drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the main routes of drug administration?

A
  • enteral (involves the gastrointestinal tract)
  • parenteral (independent of the GI tract)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the routes of parenteral drug administration?

A
  • injection:
    i) intramuscular (to muscles);
    ii) subcutaneous (to subcutaneous);
    iii) intravascular (to veins);
    iv) epidural (to epidural space)
  • topical administration:
    i) cream,
    ii) drops,
    iii) inhaled
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the routes of enteral drug administration?

A

Most common, but least predictible
- oral: swallowing, tablet/liquid
- sublingual (under tongue)
- buccal (absorbed through membranes of the mouth)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the advantages of oral administration?

A
  • convenient - can be self-administered, pain free, easy to take
  • absorption - takes place along the whole length of the GI tract
  • cheap - compared to most other parenteral routes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the disadvantages of oral administration?

A
  • sometimes inefficient - only part of the drug may be absorbed
  • irritation to gastric mucosa - nausea and vomiting
  • destruction of drugs by gastric acid and digestive juices (e.g. erythromycin)
  • interaction with food (e.g. digoxin - fibre binding)
  • unpleasant taste of some drugs
  • onset of effect is slow
  • cannot be used in unconscious patients
  • first-pass effect - drugs absorbed from the gut are initially transported to the liver via the portal vein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is first pass effect?

A

Hepatic metabolism of a pharmacological agent when it is absorbed form the gut and delivered to the liver via the portal circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the correlation between the first-pass effect size and a drug reaching systemic circulation?

A

the greater the first-pass effect, the less a drug will reach the systemic circulation when it is administered orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is the route of administration for the drug chosen?

A
  • physical characteristics
  • speed which the drug is absorbed
  • need to bypass hepatic metabolism
  • need to achieve high concentrations at particular sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the factors influencing the rate of absorption?

A
  • routes of administration
  • dosage forms
  • concentration of the drug
  • physiochemical properties of the drug
  • protein binding
  • types of transport
  • circulation at the site of absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the mechanisms of solute transport across membranes?

A
  • passive diffusion
  • filtration and bulk flow
  • endocytosis
  • ion-pairing
  • active transport
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the barriers to absorption?

A
  • mucous layers (orally administered)
  • protein binding (drugs bind bulky proteins)
  • fat isolation (sequestered in fat, when dissolves in fat)
  • placenta
  • blood-brain barrier
  • cell membrane most ubiquitous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does pKa for drug absorption determine?

A

pH at which 50% of a drug is ionised;
ionization usually increases with opposing pH, ie basic drugs ionized in acidic solutions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When do weak acid drugs become highly ionised?

A

as pH increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When do weak bases become highly ionised?

A

as pH decreases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Where are non-ionised forms soluble? Do they cross the membrane?

A

Non-ionised forms are lipid soluble and cross the cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Where are ionised forms soluble? Do they cross the membrane?

A

Ionised forms are water soluble and do not cross the cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When do drugs become most concentrated?

A

When they are most ionised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How are ionisation ratios calculated for acidic and basic drugs?

A

According to Henderson-Hasselbach equation:
for acid drugs: pKa = pH + log10([HA]unionised/[A-]ionised)
for basic drugs: pKa = pH + log10([HB+]ionised/[B]unionised)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What’s the ratio of unionised concentration across a cell membrane?

A

unionised concentration is the same on both sides

22
Q

How and why is the solubility changed of a drug for its metabolism?

A

Lipid soluble drugs are transformed to water soluble drugs to enhance secretion

23
Q

What is the primary site for metabolism of a drug?

A

Often liver, other sites include kidney, intestine, lungs

24
Q

What are the cellular sites for metabolism of a drug?

A

Cytosol, mitochondria, lysosomes, smooth endoplasmic reticulum

25
Q

What are the two types of biotransformation?

A
  • Phase I (catabolic): oxidation/reduction/hydrolysis reactions
  • Phase II (anabolic): conjugation reactions - addition of substituent group
26
Q

What are the types of Phase I reactions during biotransformation? Where and by what are they carried out?

A

1) oxidation reactions (most common) - carried out by liver cytochrome P450 system, e.g. benzodiazepines
2) reduction reactions - carried out by liver cytochrome P450 system, e.g. methadone
3) hydrolysis reactions - usually at sites other than liver, e.g. oxytocin

27
Q

What Cytochrome P450 monooxygenase is responsible for metabolism of ~60% of all drugs? What kind of drugs?

A

It is CYP3A4
- Cyclosporin (immunosuppressant)
- Tamoxifen (chemotherapeutic)
- Clotrimazole (antifungal)
- Citalopram (SSRI antidepressant)
- Haloperidol (antipsychotic)
- Methadone (opiate)
- Flunitrazepam (benzodiazepine)

28
Q

What are the dangers of CYP3A4 being responsible for metabolism of around 60% of the drugs?

A

Competition for the enzyme, problem if taking multiple drugs

29
Q

What are the inhibitors of CYP3A4? What do they do?

A

e.g. cimetidine (H2-receptor antagonist)
They prolong the action of drugs or inhibit action of those biotransformed to active agents (pro-drugs) by CYP3A4

30
Q

What are the inducers of CYP3A4? What do they do?

A

e.g. barbiturates, carbamazepine (anticonvulsant)
They shorten the action of drugs or increase effects of those biotransformed to active agents by CYP3A4

31
Q

What are the clinical implications of metabolism of imipramine?

A

Imipramine is a typical tricyclic antidepressant.
The hydroxylating enzyme, CYP2D6, is subject to genetic polymorphism, which may account for individual variation in response to tricyclic antidepressants. It naturally has different levels of activity.

32
Q

How does CYP1A1 cause health implications during metabolism?

A

CYP1A1 is responsible for converting the relatively innocuous compound benzopyrene from cigarette smoke into a carcinogen.

33
Q

What is Phase II metabolism?

A

These involve the conjugation of a drug with an endogenous chemical to form a polar (ionised) drug which can be more easily excreted.
i.e. a molecule endogenous to the body donates a portion of itself to the foreign molecule (adding extra group to the drug)

34
Q

What are the possible Phase II reactions during metabolism?

A
  • glucuronide conjugation
  • acetylation
  • methylation
35
Q

What is glucuronide conjugation during Phase II metabolism?

A

The microsomal enzyme glucuronyl transferase conducts the donation of glucuronic acid from endogenously synthesized UDPGA to various substrates (eg morphine) to form glucuronide conjugates.

36
Q

What are the limits of Phase II metabolism? Example with Paracetamol

A

Following ingestion, >90% of acetaminophen (paracetamol) is metabolised by glucuronidation and
sulphation. A fraction (<5-10%) is metabolized by predominately CYP2E1 to N-acetyl-p-
benzoquinoneimine (NAPQI), a toxic metabolite
. Under normal conditions NAPQI is
detoxified through conjugation with glutathione. Overdose (~70,000 in UK last year) treated
with N-acetyl-cysteine.

37
Q

What are the types of Phase II metabolism?

A
  • Microsomal enzymes
  • Non-microsomal enzymes
38
Q

Describe microsomal enzymes in Phase II metabolism

A
  • catalyse glucuronide conjugation and most oxidation reactions
  • located in the liver
  • lack specificity - requiring only that the drug be lipid soluble
  • inducible by drugs or other foreign substances
39
Q

Describe non-microsomal enzymes in Phase II metabolism

A
  • catalyse the other types of conjugation reactions and most hydrolysis reactions
  • widely distributed in plasma and other tissues
  • degrade polar substances which do not penetrate the microsomes
  • not inducible
40
Q

What is the principle organ of excretion of drugs? What does it excrete?

A

Kidney, via urine.
Excretes all water soluble drugs; lipid soluble drugs are reabsorbed

41
Q

How do changes in urinary pH affect the excretion of drugs?

A
  • acidic drugs are excreted in alkaline urine
  • basic drugs are excreted in acidic urine
42
Q

What are the applications of changing urinary pH?

A
  • poisoning where elimination of the drug in the urine i desirable: adjust urine pH or dialyse blood against a solution with appropriate pH
  • enhance access of a drug e.g. UTI: if a sulphonamide is being used it helps the urine be made alkaline
43
Q

What are other routes of excretion than urine?

A
  • in faeces: purgatives, liquid paraffin
  • in exhaled air: volatile anaesthetics, alcohol
  • in saliva and sweat: rifampin (antibiotic), iodides
  • in milk: metronidazole (antibiotic), phenytoin
44
Q

what are the possible order of kinetics of drug elimination?

A

zero or first order

45
Q

When do zero order kinetics take place in elimination? What is the amount of the drug cleared?

A

When substrate concentration exceeds the capacity of the enzyme system the rate of the elimination of drug is constant irrespective of the plasma concentration. Constant amount of drug is eliminated in unit time, e.g. ethanol
80 mg -> 70 mg -> 60 mg -> 50 mg

46
Q

When do first order kinetics take place in elimination? What is the amount of the drug cleared?

A

The rate of removal is proportional to the concentration of substrate (drug). For most drugs, rate of elimination is proportional to the plasma concentration, constant fraction of the drug is eliminated in unit time
80 mg -> 40 mg -> 20 mg -> 10 mg

47
Q

What is the half-life of the drug?

A

If drug has a half-life it must follow first order kinetics. It is related to the rate constant of elimination

48
Q

What is the plasma half-life?

A

The time required for the drug to reduce to half its original plasma concentration.

49
Q

What is the aim of drug dosing?

A

To reach a steady state that lies between the therapeutic threshold and the threshold of toxicity

50
Q

What does the time to reach the steady state depend upon?

A

Depends upon on the half-life of the drug, but it is independent of the dose rate.

51
Q

Why is the loading dose for a drug needed?

A

Long intervals may not be acceptable for drugs whose action is required promptly. Using a loading dose regime can shorten the time to reach steady state. Of considerable use in clinical practice when speedy therapeutic intervention is required.